FIVE BELOW (FIVE) Fundamental Analysis & Valuation

NASDAQ:FIVE • US33829M1018

Current stock price

221.72 USD
-5.07 (-2.24%)
At close:
221.5 USD
-0.22 (-0.1%)
After Hours:

This FIVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. FIVE Profitability Analysis

1.1 Basic Checks

  • In the past year FIVE was profitable.
  • FIVE had a positive operating cash flow in the past year.
  • Each year in the past 5 years FIVE has been profitable.
  • FIVE had a positive operating cash flow in each of the past 5 years.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 200M 400M

1.2 Ratios

  • With a decent Return On Assets value of 6.43%, FIVE is doing good in the industry, outperforming 78.05% of the companies in the same industry.
  • FIVE has a better Return On Equity (15.79%) than 75.61% of its industry peers.
  • FIVE has a Return On Invested Capital of 7.99%. This is in the better half of the industry: FIVE outperforms 72.36% of its industry peers.
  • FIVE had an Average Return On Invested Capital over the past 3 years of 8.48%. This is below the industry average of 13.16%.
Industry RankSector Rank
ROA 6.43%
ROE 15.79%
ROIC 7.99%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.96%, FIVE belongs to the top of the industry, outperforming 83.74% of the companies in the same industry.
  • FIVE's Profit Margin has declined in the last couple of years.
  • FIVE has a Operating Margin of 8.88%. This is amongst the best in the industry. FIVE outperforms 81.30% of its industry peers.
  • FIVE's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 35.63%, FIVE is in line with its industry, outperforming 47.97% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 8.88%
PM (TTM) 6.96%
GM 35.63%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. FIVE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FIVE is destroying value.
  • FIVE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, FIVE has less shares outstanding
  • There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B

2.2 Solvency

  • FIVE has an Altman-Z score of 4.52. This indicates that FIVE is financially healthy and has little risk of bankruptcy at the moment.
  • FIVE has a better Altman-Z score (4.52) than 86.99% of its industry peers.
  • FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.52
ROIC/WACC0.88
WACC9.08%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B

2.3 Liquidity

  • FIVE has a Current Ratio of 1.60. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of FIVE (1.60) is better than 65.04% of its industry peers.
  • A Quick Ratio of 0.59 indicates that FIVE may have some problems paying its short term obligations.
  • FIVE has a Quick ratio (0.59) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.59
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. FIVE Growth Analysis

3.1 Past

  • FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.90%, which is quite good.
  • FIVE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.07% yearly.
  • Looking at the last year, FIVE shows a quite strong growth in Revenue. The Revenue has grown by 15.78% in the last year.
  • Measured over the past years, FIVE shows a quite strong growth in Revenue. The Revenue has been growing by 15.99% on average per year.
EPS 1Y (TTM)11.9%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%61.9%
Revenue 1Y (TTM)15.78%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.06%

3.2 Future

  • FIVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.76% yearly.
  • Based on estimates for the next years, FIVE will show a quite strong growth in Revenue. The Revenue will grow by 16.48% on average per year.
EPS Next Y28.27%
EPS Next 2Y18.51%
EPS Next 3Y16.14%
EPS Next 5Y30.76%
Revenue Next Year22.44%
Revenue Next 2Y16.48%
Revenue Next 3Y14.25%
Revenue Next 5Y16.48%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

3

4. FIVE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 38.03, FIVE can be considered very expensive at the moment.
  • FIVE's Price/Earnings is on the same level as the industry average.
  • FIVE is valuated expensively when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 31.32 indicates a quite expensive valuation of FIVE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, FIVE is valued a bit more expensive.
Industry RankSector Rank
PE 38.03
Fwd PE 31.32
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • FIVE's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FIVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.87
EV/EBITDA 20.3
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of FIVE may justify a higher PE ratio.
  • FIVE's earnings are expected to grow with 16.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.35
PEG (5Y)3.78
EPS Next 2Y18.51%
EPS Next 3Y16.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FIVE Dividend Analysis

5.1 Amount

  • No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FIVE Fundamentals: All Metrics, Ratios and Statistics

FIVE BELOW

NASDAQ:FIVE (3/27/2026, 8:17:22 PM)

After market: 221.5 -0.22 (-0.1%)

221.72

-5.07 (-2.24%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-18
Earnings (Next)06-02
Inst Owners105.59%
Inst Owner Change95.16%
Ins Owners0.85%
Ins Owner Change-3.64%
Market Cap12.23B
Revenue(TTM)4.43B
Net Income(TTM)307.87M
Analysts76.25
Price Target257.34 (16.07%)
Short Float %3.98%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.66%
Min EPS beat(2)29.03%
Max EPS beat(2)174.29%
EPS beat(4)4
Avg EPS beat(4)51.97%
Min EPS beat(4)1.27%
Max EPS beat(4)174.29%
EPS beat(8)5
Avg EPS beat(8)42.48%
EPS beat(12)7
Avg EPS beat(12)29.19%
EPS beat(16)8
Avg EPS beat(16)27.52%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.37%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.87%
Revenue beat(8)3
Avg Revenue beat(8)-0.28%
Revenue beat(12)3
Avg Revenue beat(12)-0.63%
Revenue beat(16)4
Avg Revenue beat(16)-0.91%
PT rev (1m)2.8%
PT rev (3m)19.88%
EPS NQ rev (1m)0.73%
EPS NQ rev (3m)13.69%
EPS NY rev (1m)1.39%
EPS NY rev (3m)22.23%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)5.93%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)3.61%
Valuation
Industry RankSector Rank
PE 38.03
Fwd PE 31.32
P/S 2.76
P/FCF 37.87
P/OCF 24.02
P/B 6.27
P/tB 6.27
EV/EBITDA 20.3
EPS(TTM)5.83
EY2.63%
EPS(NY)7.08
Fwd EY3.19%
FCF(TTM)5.86
FCFY2.64%
OCF(TTM)9.23
OCFY4.16%
SpS80.25
BVpS35.36
TBVpS35.36
PEG (NY)1.35
PEG (5Y)3.78
Graham Number68.1
Profitability
Industry RankSector Rank
ROA 6.43%
ROE 15.79%
ROCE 10.65%
ROIC 7.99%
ROICexc 9.31%
ROICexgc 9.31%
OM 8.88%
PM (TTM) 6.96%
GM 35.63%
FCFM 7.3%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexgc growth 3Y-24.82%
ROICexgc growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score9
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 98.65%
Cap/Sales 4.2%
Interest Coverage 250
Cash Conversion 87.48%
Profit Quality 104.9%
Current Ratio 1.6
Quick Ratio 0.59
Altman-Z 4.52
F-Score9
WACC9.08%
ROIC/WACC0.88
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)11.9%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%61.9%
EPS Next Y28.27%
EPS Next 2Y18.51%
EPS Next 3Y16.14%
EPS Next 5Y30.76%
Revenue 1Y (TTM)15.78%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.06%
Revenue Next Year22.44%
Revenue Next 2Y16.48%
Revenue Next 3Y14.25%
Revenue Next 5Y16.48%
EBIT growth 1Y13.83%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year86.56%
EBIT Next 3Y31.72%
EBIT Next 5Y30.4%
FCF growth 1Y128.3%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y12.68%
OCF growth 3Y9.51%
OCF growth 5Y18.16%

FIVE BELOW / FIVE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FIVE BELOW (FIVE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to FIVE.


What is the valuation status of FIVE BELOW (FIVE) stock?

ChartMill assigns a valuation rating of 3 / 10 to FIVE BELOW (FIVE). This can be considered as Overvalued.


Can you provide the profitability details for FIVE BELOW?

FIVE BELOW (FIVE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of FIVE BELOW (FIVE) stock?

The Price/Earnings (PE) ratio for FIVE BELOW (FIVE) is 38.03 and the Price/Book (PB) ratio is 6.27.


Is the dividend of FIVE BELOW sustainable?

The dividend rating of FIVE BELOW (FIVE) is 0 / 10 and the dividend payout ratio is 0%.